Departments Letter to the Editor| Volume 96, ISSUE 4, P760-761, April 2015

The Authors Respond

Published:January 20, 2015DOI:
      We thank Lin for valuable comments on our article.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Physical Medicine and Rehabilitation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Linked Article

      • Predicting the Response to Botulinum Toxin Treatment in Children With Cerebral Palsy
        Archives of Physical Medicine and RehabilitationVol. 96Issue 4
        • Preview
          It is interesting to read the article by Bar-On et al.1 They compared the responsiveness of clinical and instrumented spasticity assessment for the effects of botulinum toxin type A injection in children with cerebral palsy. However, in the entire article, they used the abbreviated term BTX rather than the distinct trade name for botulinum toxin to denote the medication they injected. I strongly recommend that the authors need to clarify the formulation of botulinum toxin to avoid misunderstanding.
        • Full-Text
        • PDF